It binds to a wide range of SSTR subtypes (SSTR2, SSTR3, and SSTR5) and has shown promise in diagnosing a variety of tumor types [51–53], including some OctreoScan negative NETs [10]. The gene discussed is SSTR2; the disease is neoplasm.